LONG-TERM (5 YEARS) EFFICACY AND SAFETY OF INFLIXIMAB IN CROHN DISEASE PATIENTS

(1) CHOP

(2) Arquitecto Marcide

(3) POVISA

(4) CHUVI

(5) CHOU

(6) Lucus Augusti

(7) UNIVERSITY HOSPITAL SANTIAGO



This item was part of the IBD I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A192